IDH1 and central nervous system cancer: Glioblastoma (GBM, WHO grade 4 glioma, IDH-wildtype) is the most aggressive primary brain tumor in adults with a dismal median overall survival (OS) of only 12 to 18 months and a 5-year OS rate of 6.8% (1, 2).